201 related articles for article (PubMed ID: 21505147)
1. Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women.
Brinkoetter M; Magkos F; Vamvini M; Mantzoros CS
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E99-E104. PubMed ID: 21505147
[TBL] [Abstract][Full Text] [Related]
2. Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.
Vamvini MT; Aronis KN; Chamberland JP; Mantzoros CS
J Clin Endocrinol Metab; 2011 Nov; 96(11):3416-23. PubMed ID: 21865351
[TBL] [Abstract][Full Text] [Related]
3. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.
Sienkiewicz E; Magkos F; Aronis KN; Brinkoetter M; Chamberland JP; Chou S; Arampatzi KM; Gao C; Koniaris A; Mantzoros CS
Metabolism; 2011 Sep; 60(9):1211-21. PubMed ID: 21741057
[TBL] [Abstract][Full Text] [Related]
4. Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.
Matarese G; La Rocca C; Moon HS; Huh JY; Brinkoetter MT; Chou S; Perna F; Greco D; Kilim HP; Gao C; Arampatzi K; Wang Z; Mantzoros CS
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):E818-27. PubMed ID: 23382191
[TBL] [Abstract][Full Text] [Related]
5. Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.
Moragianni VA; Aronis KN; Chamberland JP; Mantzoros CS
J Clin Endocrinol Metab; 2011 Dec; 96(12):3750-8. PubMed ID: 21917874
[TBL] [Abstract][Full Text] [Related]
6. Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise.
Perakakis N; Mougios V; Fatouros I; Siopi A; Draganidis D; Peradze N; Ghaly W; Mantzoros CS
J Clin Endocrinol Metab; 2018 Oct; 103(10):3890-3899. PubMed ID: 30085147
[TBL] [Abstract][Full Text] [Related]
7. Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels.
Ángel García-Merino J; Moreno-Pérez D; de Lucas B; Montalvo-Lominchar MG; Muñoz E; Sánchez L; Naclerio F; Herrera-Rocha KM; Moreno-Jiménez MR; Rocha-Guzmán NE; Larrosa M
Food Funct; 2020 Apr; 11(4):3441-3450. PubMed ID: 32236212
[TBL] [Abstract][Full Text] [Related]
8. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.
Bowser M; Herberg S; Arounleut P; Shi X; Fulzele S; Hill WD; Isales CM; Hamrick MW
Exp Gerontol; 2013 Feb; 48(2):290-7. PubMed ID: 23178301
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.
Perakakis N; Upadhyay J; Ghaly W; Chen J; Chrysafi P; Anastasilakis AD; Mantzoros CS
Metabolism; 2018 Aug; 85():240-249. PubMed ID: 29752954
[TBL] [Abstract][Full Text] [Related]
10. Leptin administration in physiological or pharmacological doses does not alter circulating irisin levels in humans.
Gavrieli A; Panagiotou G; Mantzoros CS
Int J Obes (Lond); 2016 Sep; 40(9):1461-3. PubMed ID: 27200503
[TBL] [Abstract][Full Text] [Related]
11. Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.
Bouzoni E; Perakakis N; Mantzoros CS
Metabolism; 2020 Dec; 113():154392. PubMed ID: 33045195
[TBL] [Abstract][Full Text] [Related]
12. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.
Heymsfield SB; Greenberg AS; Fujioka K; Dixon RM; Kushner R; Hunt T; Lubina JA; Patane J; Self B; Hunt P; McCamish M
JAMA; 1999 Oct; 282(16):1568-75. PubMed ID: 10546697
[TBL] [Abstract][Full Text] [Related]
13. Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice.
Choi SJ; Yablonka-Reuveni Z; Kaiyala KJ; Ogimoto K; Schwartz MW; Wisse BE
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1031-7. PubMed ID: 21427410
[TBL] [Abstract][Full Text] [Related]
14. Preadipocyte factor-1 levels are higher in women with hypothalamic amenorrhea and are associated with bone mineral content and bone mineral density through a mechanism independent of leptin.
Aronis KN; Kilim H; Chamberland JP; Breggia A; Rosen C; Mantzoros CS
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1634-9. PubMed ID: 21795455
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance.
Moon HS; Matarese G; Brennan AM; Chamberland JP; Liu X; Fiorenza CG; Mylvaganam GH; Abanni L; Carbone F; Williams CJ; De Paoli AM; Schneider BE; Mantzoros CS
Diabetes; 2011 Jun; 60(6):1647-56. PubMed ID: 21617185
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
Hofmann M; Halper B; Oesen S; Franzke B; Stuparits P; Tschan H; Bachl N; Strasser EM; Quittan M; Ploder M; Wagner KH; Wessner B
Exp Gerontol; 2015 Apr; 64():35-45. PubMed ID: 25681638
[TBL] [Abstract][Full Text] [Related]
17. The effect of rate of weight reduction on serum myostatin and follistatin concentrations in competitive wrestlers.
Motevalli MS; Dalbo VJ; Attarzadeh RS; Rashidlamir A; Tucker PS; Scanlan AT
Int J Sports Physiol Perform; 2015 Mar; 10(2):139-46. PubMed ID: 24911427
[TBL] [Abstract][Full Text] [Related]
18. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
[TBL] [Abstract][Full Text] [Related]
19. Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.
Anastasilakis AD; Polyzos SA; Skouvaklidou EC; Kynigopoulos G; Saridakis ZG; Apostolou A; Triantafyllou GA; Karagiozoglou-Lampoudi T; Mantzoros CS
Metabolism; 2016 Oct; 65(10):1459-65. PubMed ID: 27621181
[TBL] [Abstract][Full Text] [Related]
20. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
